HAEMONETICS CORP financial metrics

Professional SEC-based dashboard for profitability, financial health, and growth with transparent scoring logic. Latest period: Q4 2025.

Symbol
HAE on NYSE
Location
Boston, MA
Fiscal year end
28 March
Latest financial report
05 Feb 2026

Quick Takeaways

  • HAE - HAEMONETICS CORP financial facts are built from SEC company filings data.
  • Latest metrics period on this page: Q4 2025.
  • Headline metric: Return On Equity 19%.

What Changed

  • Return On Equity YoY change: <span class="text-green-600">+37%</span>.
  • Most recent SEC facts end date: 30 Jan 2026.

Why This Matters

  • This gives a beginner-friendly first read before you inspect detailed formulas and metric tables.
  • Every metric card links to a deeper SEC-backed history page for verification.

Official SEC Source

Based on latest 10-Q/10-K

Facts and ratios are grounded in SEC company facts linked to the latest 10-Q/10-K cycle.

See Original Filing

Latest SEC snapshot (2026-01-30) highlights Return On Equity 19.3%, Return On Assets 6.4%, and Operating Margin 21.0%.

Financial Quality Score

Transparent 0-100 scoring model based on profitability, financial health, and growth factors.

69.2/100

Balanced Confidence high

Return On Equity

19%

Metric score 66.5/100

Return On Assets

6.4%

Metric score 55.6/100

Financial Health

Current Ratio
1.75x
Quick Ratio
1.04x
Debt to Equity
1.34x

Strengths

Operating Margin, Current Ratio, and Quick Ratio

Watchpoints

Debt-to-equity and Revenues YoY

Key metrics snapshot

Return On Equity

19%

YoY: +37%

Industry median: -17% (n=179)

View history

Return On Assets

6.4%

YoY: +27%

Industry median: -34% (n=178)

View history

Operating Margin

21%

YoY: +45%

Industry median: -18% (n=127)

View history

Current Ratio

1.75x

YoY: -56%

Industry median: 2.36x (n=176)

View history

Quick Ratio

1.04x

YoY: -51%

Industry median: 1.49x (n=146)

View history

Debt-to-equity

1.34x

YoY:

Industry median: 0.46x (n=133)

View history

Revenues YoY

-4%

YoY:

Industry median: 15% (n=128)

View history

NetIncomeLoss YoY

35%

YoY:

Industry median: 0.49% (n=168)

View history

Profitability

Metric Latest value YoY change
Return On Equity 19% +37%
Return On Assets 6.4% +27%
Operating Margin 21% +45%

Financial Health

Metric Latest value YoY change
Current Ratio 1.75x -56%
Quick Ratio 1.04x -51%
Debt-to-equity 1.34x

Growth

Metric Latest value YoY change
Revenues YoY -4%
NetIncomeLoss YoY 35%

Share Metrics

Metric Latest value YoY change
Entity Common Stock, Shares Outstanding 46,471,350 -7.5%
Common Stock, Shares, Outstanding 46,829,249 -6.8%
Common Stock, Value, Issued $468,000 -6.8%
Weighted Average Number of Shares Outstanding, Basic 46,792,000 -6.9%
Weighted Average Number of Shares Outstanding, Diluted 46,987,000 -7.2%

Additional Metrics

Metric Latest value YoY change
Revenue from Contract with Customer, Excluding Assessed Tax $1,318,275,000 -4%
Research and Development Expense $63,625,000 +5.6%
Operating Income (Loss) $251,094,000 +39%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $227,166,000 +38%
Income Tax Expense (Benefit) $51,730,000 +49%
Earnings Per Share, Basic 3.65 +43%
Earnings Per Share, Diluted 3.63 +43%
Cash and Cash Equivalents, at Carrying Value $363,367,000 +13%
Accounts Receivable, after Allowance for Credit Loss, Current $195,707,000 -7.7%
Inventory, Net $321,185,000 -11%
Assets, Current $943,674,000 -6.2%
Deferred Income Tax Assets, Net $7,329,000 -8.4%
Property, Plant and Equipment, Net $297,234,000 +3.9%
Intangible Assets, Net (Excluding Goodwill) $419,734,000 -9.9%
Goodwill $606,825,000 +0.26%
Other Assets, Noncurrent $216,094,000 +35%
Assets $2,490,890,000 -1.6%
Accounts Payable, Current $48,694,000 -23%
Employee-related Liabilities, Current $52,099,000 +13%
Liabilities, Current $539,868,000 +113%
Deferred Income Tax Liabilities, Net $55,979,000 -8.9%
Other Liabilities, Noncurrent $63,605,000 -29%
Accumulated Other Comprehensive Income (Loss), Net of Tax $34,610,000 +38%
Retained Earnings (Accumulated Deficit) $381,091,000 -2.8%
Stockholders' Equity Attributable to Parent $911,451,000 +0.51%
Liabilities and Equity $2,490,890,000 -1.6%
Common Stock, Shares Authorized 150,000,000 0%
Common Stock, Shares, Issued 46,829,249 -6.8%
Common Stock, Par or Stated Value Per Share 0.01 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $363,367,000 +13%
Depreciation $61,000,000 +2.5%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $196,327,000 +98%
Property, Plant and Equipment, Gross $836,814,000 -3.5%
Amortization of Intangible Assets $51,500,000 -7.4%
Share-based Payment Arrangement, Expense $31,637,000 -5.1%

How we score

This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.

Metric Weight V1 threshold
ROIC205% to 20%
ROE158% to 25%
ROA102% to 10%
Operating Margin55% to 25%
Current Ratio121.0x to 2.0x
Quick Ratio80.8x to 1.5x
Debt to Equity100.3x to 2.0x (lower is better)
Revenue YoY10-10% to +20%
Net Income YoY10-10% to +20%

How Calculated (standard_v1)

Metrics are computed with a market-consensus convention designed for cross-portal comparability.

  • TTM Operating Income / TTM Revenues
  • Current Assets / Current Liabilities (latest instant quarter)
  • (Current Assets - Inventory) / Current Liabilities; fallback: (Cash+Short-Term Investments + Accounts Receivable) / Current Liabilities
  • Total Debt / Stockholders Equity (latest instant quarter; shared unit; freshest series)
  • TTM Net Income / Average Equity (current quarter + same quarter previous year) / 2
  • TTM Net Income / Average Assets (current quarter + same quarter previous year) / 2
  • TTM NOPAT / Average Invested Capital, where NOPAT=Operating Income*(1-tax rate), Invested Capital=Equity+Total Debt-Cash & ST Investments
  • TTM Revenues YoY
  • TTM Net Income YoY